Identification and regulation of bone morphogenetic protein antagonists associated with preantral follicle

Mark A Fenwick1, Yosef T Mansour, Stephen Franks

  • 1Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom. m.fenwick@imperial.ac.uk

Endocrinology
|July 28, 2011
PubMed

Insights

Bone morphogenetic proteins (BMP) regulate early follicle development. Key antagonists like Twsg1, Htra1, Nbl1, and Fst are highly expressed in granulosa cells, indicating local ovarian regulation.

Area of Science:

  • Reproductive biology
  • Endocrinology
  • Molecular biology

Background:

  • Bone morphogenetic proteins (BMP) are crucial for early follicle development, acting independently of gonadotropins.
  • BMP signaling gradients, modulated by antagonists, are essential for establishing follicular cell fate.
  • Understanding BMP antagonists is key to deciphering paracrine signaling in early folliculogenesis.

Purpose of the Study:

  • To identify BMP antagonists involved in regulating paracrine signaling during early ovarian follicle development.
  • To investigate the expression patterns of candidate BMP antagonist genes in juvenile mouse ovaries.
  • To explore the role of local factors in modulating BMP antagonist activity.

Main Methods:

  • Quantitative RT-PCR was used to assess candidate gene transcript changes in juvenile mouse ovaries at different ages.
  • In situ hybridization and immunohistochemistry were employed to determine the localization of key antagonist genes.
  • In vitro experiments exposed preantral follicles to FSH to assess antagonist response to hormonal stimulation.

Main Results:

  • Several BMP antagonists (Nog, Htra1, Fst, Bmper, Vwc2) showed positive association with follicle emergence, while Sostdc1 and Chrd expression decreased.
  • Twsg1, Htra1, Nbl1, and Fst were consistently highly expressed in granulosa cells of developing follicles.
  • FSH stimulation in vitro did not significantly alter the levels of most antagonists (except Nbl1), suggesting local regulation.

Conclusions:

  • The juvenile ovary expresses multiple BMP antagonists, with high levels in developing follicles.
  • These antagonists are primarily regulated by local intraovarian factors, not systemic hormones like FSH.
  • This highlights a significant layer of local control over growth factor actions during folliculogenesis.

Related Concept Videos

Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...